Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ropivacaine ± morphine dose–response in anorectal surgery
ChiCTR2000040742Phase 4Recruiting
- Sponsor
- Chengdu Fifth People's Hospital
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and morphine in hemorrhoid and anorectal surgical condition (2 arms), sponsored by Chengdu Fifth People's Hospital. Primary endpoints: effect of spinal anesthesia and effect of postoperative analgesia. Started Jan 2021; status: recruiting.
02
Drugs
ropivacainemorphine
03
Conditions
hemorrhoidanorectal surgical condition
Beyond the preview
Go deeper on ChiCTR2000040742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040742.